Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others. It also operates as an agent to trade in OTC energy products using knowledge of the energy sector and relationships with clients for oil, power and gas, and shipping and freight products; and provides market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates. Additionally, it offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. The company operates in the United Kingdom, the United States, and internationally. Marex Group plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Marex Group plc

Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Immuneering today and set a price target of $12.00. Suvannavejh covers the H...

Mizuho Securities Reaffirms Their Buy Rating on Immuneering (IMRX)

An update from Immuneering ( ($IMRX) ) is now available. On June 11, 2026, Immuneering Corporation’s board appointed veteran biotech executive Andr...

Immuneering Appoints Veteran Biotech Leader as New CFO

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amneal Pharmaceuticals (AMRX), Evolent Health (EVH) ...

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH) and Celldex (CLDX)

Immuneering ( ($IMRX) ) has shared an update. Immuneering Corporation held its Annual Meeting of Stockholders on June 11, 2026, with 44,495,059 Cla...

Immuneering Shareholders Approve Directors and Auditor at Meeting

Marex Group plc ( ($MRX) ) has shared an update. On 9 June 2026, Marex Group plc completed a U.S.$500 million offering of perpetual subordinated re...

Marex Raises $500 Million in Hybrid Notes to Refinance Capital and Fund Acquisitions

Marex Group plc ( ($MRX) ) has shared an announcement. Marex Group plc, a diversified global financial services platform listed on Nasdaq, provides...

Marex Group Adds Fintech Entrepreneur Georges Assi to Board and Risk Committee

The latest announcement is out from Immuneering ( ($IMRX) ). On June 1, 2026, Immuneering reported updated Phase 2a data for atebimetinib, a once-d...

Immuneering Advances Atebimetinib With Positive Phase 2a Results

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immuneering (IMRX) and Immunocore Holdings (IMCR) wi...

Analysts’ Top Healthcare Picks: Immuneering (IMRX), Immunocore Holdings (IMCR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amneal Pharmaceuticals (AMRX), HUGroup Holdings (MRC...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amneal Pharmaceuticals (AMRX), Immunovant (IMVT) and...

Analysts’ Top Healthcare Picks: Amneal Pharmaceuticals (AMRX), Immunovant (IMVT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Glaukos (GKOS) and CareCloud (CC...

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Glaukos (GKOS) and CareCloud (CCLD)

An announcement from Marex Group plc ( ($MRX) ) is now available. Marex Group plc held its Annual General Meeting on 21 May 2026 in London, where s...

Market Cap	$4.56B	P/E Ratio	12.12
52W High	$58.62	52W Low	$27.91
Div Yield	64.0%	Payout Ratio	12.5%
EPS Growth 3Y	0.0%	52W Position	120.3%
Overall Score	79	Value Score	100
Quality Score	47	Technical Score	91

EPS Current Est	$5.35	EPS Next Est	$6.17
EPS Growth Est	+15.3%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRX	$64.85	+5.29%	1.40M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRX	$64.85	+5.3%	1.40M
3
4
5
6

MRX

MRX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Marex Group plc Data in Excel

Get Marex Group plc Data in Excel